Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $119,812 | 54 | 92.0% |
| Food and Beverage | $3,567 | 33 | 2.7% |
| Travel and Lodging | $2,225 | 4 | 1.7% |
| Grant | $2,000 | 1 | 1.5% |
| Unspecified | $1,694 | 11 | 1.3% |
| Education | $957.78 | 13 | 0.7% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AMAG Pharmaceuticals, Inc. | $114,050 | 82 | $0 (2023) |
| Sage Therapeutics, Inc. | $4,005 | 3 | $0 (2022) |
| Quidel Corporation | $3,000 | 2 | $0 (2023) |
| Kyowa Kirin, Inc. | $2,400 | 1 | $0 (2023) |
| Roche Diagnostics Corporation | $2,000 | 1 | $0 (2020) |
| Janssen Global Services, LLC | $1,740 | 1 | $0 (2023) |
| Kyowa Hakko Kirin Co., Ltd | $800.00 | 1 | $0 (2019) |
| Hologic, LLC | $653.61 | 8 | $0 (2018) |
| Vertex Pharmaceuticals Incorporated | $525.00 | 1 | $0 (2023) |
| Xellia Pharmaceuticals | $500.00 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $8,327 | 6 | Kyowa Kirin, Inc. ($2,400) |
| 2022 | $42,533 | 11 | AMAG Pharmaceuticals, Inc. ($40,202) |
| 2020 | $23,293 | 8 | AMAG Pharmaceuticals, Inc. ($18,313) |
| 2019 | $52,369 | 63 | AMAG Pharmaceuticals, Inc. ($51,550) |
| 2018 | $2,521 | 13 | AMAG Pharmaceuticals, Inc. ($2,263) |
| 2017 | $1,213 | 15 | HOLOGIC INC ($525.82) |
All Payment Transactions
116 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/21/2023 | Janssen Global Services, LLC | — | Consulting Fee | Cash or cash equivalent | $1,740.00 | General |
| 10/19/2023 | Kyowa Kirin, Inc. | — | Consulting Fee | Cash or cash equivalent | $2,400.00 | General |
| 03/10/2023 | Vertex Pharmaceuticals Incorporated | — | Consulting Fee | Cash or cash equivalent | $525.00 | General |
| 03/09/2023 | Quidel Corporation | — | Consulting Fee | Cash or cash equivalent | $1,800.00 | General |
| 03/08/2023 | AMAG Pharmaceuticals, Inc. | MAKENA (Drug) | Travel and Lodging | Cash or cash equivalent | $1,362.15 | General |
| Category: Reduction of risk for preterm birth | ||||||
| 03/08/2023 | Xellia Pharmaceuticals | — | Consulting Fee | Cash or cash equivalent | $500.00 | General |
| 12/07/2022 | AMAG Pharmaceuticals, Inc. | MAKENA (Drug) | Consulting Fee | Cash or cash equivalent | $36,120.00 | General |
| Category: Reduction of risk for preterm birth | ||||||
| 12/07/2022 | AMAG Pharmaceuticals, Inc. | MAKENA (Drug) | Consulting Fee | In-kind items and services | $617.20 | General |
| Category: Reduction of risk for preterm birth | ||||||
| 12/07/2022 | AMAG Pharmaceuticals, Inc. | MAKENA (Drug) | Consulting Fee | In-kind items and services | $59.24 | General |
| Category: Reduction of risk for preterm birth | ||||||
| 10/19/2022 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $25.55 | General |
| Category: Endocrinology | ||||||
| 10/18/2022 | AMAG Pharmaceuticals, Inc. | MAKENA (Drug) | Consulting Fee | In-kind items and services | $83.72 | General |
| Category: Reduction of risk for preterm birth | ||||||
| 10/17/2022 | AMAG Pharmaceuticals, Inc. | MAKENA (Drug) | Consulting Fee | In-kind items and services | $97.06 | General |
| Category: Reduction of risk for preterm birth | ||||||
| 09/21/2022 | AMAG Pharmaceuticals, Inc. | MAKENA (Drug) | Consulting Fee | Cash or cash equivalent | $3,225.00 | General |
| Category: Reduction of risk for preterm birth | ||||||
| 09/06/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kyleena (Drug), Mirena, Skyla | Food and Beverage | In-kind items and services | $19.86 | General |
| Category: Womens Health | ||||||
| 07/11/2022 | Sage Therapeutics, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,780.00 | General |
| 06/06/2022 | Sage Therapeutics, Inc. | ZULRESSO (Drug) | Consulting Fee | Cash or cash equivalent | $445.00 | General |
| Category: PSYCHIATRYPSYCHOLOGY | ||||||
| 05/31/2022 | Tandem Diabetes Care, Inc. | t:slim X2 Insulin Pump with Control-IQ (Device) | Food and Beverage | Cash or cash equivalent | $60.62 | General |
| Category: Endocrinology | ||||||
| 08/18/2020 | Sage Therapeutics, Inc. | ZULRESSO (Drug) | Consulting Fee | Cash or cash equivalent | $1,780.00 | General |
| Category: PSYCHIATRYPSYCHOLOGY | ||||||
| 08/04/2020 | Roche Diagnostics Corporation | CD cobas Reagents (Device) | Consulting Fee | Cash or cash equivalent | $2,000.00 | General |
| Category: Centralized Diagnostics | ||||||
| 02/22/2020 | Quidel Corporation | — | Consulting Fee | Cash or cash equivalent | $1,200.00 | General |
| 02/07/2020 | AMAG Pharmaceuticals, Inc. | MAKENA (Drug) | Consulting Fee | In-kind items and services | $85.35 | General |
| Category: REDUCTION OF RISK FOR PRETERM BIRTH | ||||||
| 02/04/2020 | AMAG Pharmaceuticals, Inc. | MAKENA (Drug) | Consulting Fee | In-kind items and services | $140.63 | General |
| Category: REDUCTION OF RISK FOR PRETERM BIRTH | ||||||
| 02/01/2020 | AMAG Pharmaceuticals, Inc. | MAKENA (Drug) | Consulting Fee | In-kind items and services | $22.17 | General |
| Category: REDUCTION OF RISK FOR PRETERM BIRTH | ||||||
| 01/08/2020 | AMAG Pharmaceuticals, Inc. | MAKENA (Drug) | Consulting Fee | Cash or cash equivalent | $16,500.00 | General |
| Category: REDUCTION OF RISK FOR PRETERM BIRTH | ||||||
| 01/08/2020 | AMAG Pharmaceuticals, Inc. | MAKENA (Drug) | Consulting Fee | Cash or cash equivalent | $1,564.91 | General |
| Category: REDUCTION OF RISK FOR PRETERM BIRTH | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A Phase 2b3a, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Efficacy and Safety of AMAG-423, a Digoxin Immune Fab, in Antepartum Subjects With Severe Preeclampsia | AMAG Pharmaceuticals, Inc. | $1,694 | 11 |
About Dr. Baha Sibai, M.D
Dr. Baha Sibai, M.D is a Obstetrics & Gynecology healthcare provider based in Houston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1942381926.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Baha Sibai, M.D has received a total of $130,256 in payments from pharmaceutical and medical device companies, with $8,327 received in 2023. These payments were reported across 116 transactions from 16 companies. The most common payment nature is "Consulting Fee" ($119,812).
Practice Information
- Specialty Obstetrics & Gynecology
- Other Specialties Critical Care Medicine, Maternal & Fetal Medicine
- Location Houston, TX
- Active Since 10/18/2006
- Last Updated 01/18/2024
- Taxonomy Code 207V00000X
- Entity Type Individual
- NPI Number 1942381926
Products in Payments
- MAKENA (Drug) $100,785
- FERAHEME (Drug) $11,439
- ZULRESSO (Drug) $2,225
- CD cobas Reagents (Device) $2,000
- ALTIS (Device) $282.37
- fFN (Device) $240.67
- Fetal Fibronectin (Device) $165.79
- FFN (Device) $146.48
- INTRAROSA (Drug) $132.96
- FETAL FIBRONECTIN (Device) $100.67
- CERVIDIL (Drug) $81.36
- Mirena (Drug) $80.14
- t:slim X2 Insulin Pump with Control-IQ (Device) $60.62
- Dexcom G6 Transmitter (Medical Supply) $25.55
- Kyleena (Drug) $19.86
- INJECTAFER (Drug) $18.92
- t-slim insulin pump (Device) $13.22
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Obstetrics & Gynecology Doctors in Houston
Dr. George Kuhn, Md, MD
Obstetrics & Gynecology — Payments: $241,556
Shannon Westin, Md, MD
Obstetrics & Gynecology — Payments: $166,777
Sandra Hurtado, M.d, M.D
Obstetrics & Gynecology — Payments: $160,121
Jimmy Espinoza, M.d, M.D
Obstetrics & Gynecology — Payments: $108,379
Nicole Tran, Md, MD
Obstetrics & Gynecology — Payments: $104,647
Dr. Daisy Ayim, Md, MD
Obstetrics & Gynecology — Payments: $102,709